[ Pharmaceutical Sciences Asia - ONLINE ]
Print ISSN 2586-8195 E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

Pharm Sci Asia ; 39(2),
 

Quality of Life among Stage III Colon Cancer Patients Receiving Oral and Intravenous Chemotherapy Regimens in Thailand

P. Lerdkiattikorn, N.Tantai, U. Chaikledkaew*, W. Lausoontornsiri, T. Khuhaprema, P.Kingkaew and Y.Teerawattananon

-


Health related quality of life for colon cancer is important for economic evaluation. The objective of this study was to measure health utility scores of oral and intravenous chemotherapy regimens in colon cancer patients with or without relapse in Thailand. The quality of life was measured in term of utility scores collected from colon cancer patients with or without relapse using EQ-5D questionnaire at National Cancer Institute, Bangkok, Thailand during January and April, 2010. A total of 48 colon cancer patients were classified equally into two groups (i.e., stage III colon cancer patients without relapse and those with relapse or stage IV colon cancer). Each group included 12 patients receiving the first-line oral capecitabine monotherapy and 12 patients receiving the first-line intravenous chemotherapy (i.e., 5- FU/LV, FOLFOX and XELOX). We obtained the average utility score as followed: stage III colon cancer patients or without relapse receiving oral chemotherapy regimen (mean=0.65, Standard error, SE=0.047), stage III colon cancer patients or without relapse receiving intravenous chemotherapy regimens (mean=0.60, SE=0.063), stage IV colon cancer or with relapse receiving oral chemotherapy regimen (mean=0.62, SE=0.043), stage IV colon cancer or with relapse receiving intravenous chemotherapy (mean=0.56, SE=0.101). However, there was no statistical significant difference in the average utility scores between oral and intravenous chemotherapy regimens in cancer patients with or without relapse.


Keyword:

Utility, Quality of life, Stage III colon cancer, EQ-5D, Thailand




Download full paper (PDF File size: 689.60 KB.)





Vol.39
No.3-4
July - December 2012

See other volume

 


Vol.39
No.2
April - June 2012

See other volume

 


Vol.39
No.1
January - March 2012

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University
Member's menu

You're now loging on with following account:
Guest (unknown)

Please Sign in or Register



    Copyright © 2017
    Faculty of Pharmacy, Mahidol University, THAILAND